Knipp lab:Research: Difference between revisions
(add link to Dec 2011 IPPH newsletter) |
mNo edit summary |
||
| Line 6: | Line 6: | ||
He has also been interested in investigating the effects of processing induced dosage form variation on clinical performance utilizing in vitro and in vivo (porcine) models. His recent work has focused on the utilization of the porcine model for testing the pharmacokinetics of novel pediatric formulations developed within his laboratory.<br /> | He has also been interested in investigating the effects of processing induced dosage form variation on clinical performance utilizing in vitro and in vivo (porcine) models. His recent work has focused on the utilization of the porcine model for testing the pharmacokinetics of novel pediatric formulations developed within his laboratory.<br /> | ||
[http://www.ipph.purdue.edu/newsletter/2011-12.pdf <strong>Research Spotlight: Pediatric Medicines - A Tough Pill to Swallow]</strong>, from the <em>Industrial & Physical Pharmacy Newsletter - December 2011 | |||
[http://www.ipph.purdue.edu/newsletter/2011-12.pdf <strong>Research Spotlight: Pediatric Medicines - A Tough Pill to Swallow]</strong>, from the <em>Industrial & Physical Pharmacy Newsletter - December 2011</em>, p. 5.<br /> | |||
</div> | </div> | ||
Revision as of 11:03, 18 December 2012
Major research interests: Dr. Knipp's research interests include the molecular and functional characterization of oligopeptide transporters, where he has been focusing on the characterization of the human Peptide/Histidine Transporter 1 isoform in human intestinal and blood brain barrier cell lines.
He is interested in determining the the effect of xenobiotics, particularly delineating the roles of DEHP and Bisphenol A, on placental fatty acid homeostasis and fetal development.
He has also been interested in investigating the effects of processing induced dosage form variation on clinical performance utilizing in vitro and in vivo (porcine) models. His recent work has focused on the utilization of the porcine model for testing the pharmacokinetics of novel pediatric formulations developed within his laboratory.
Research Spotlight: Pediatric Medicines - A Tough Pill to Swallow, from the Industrial & Physical Pharmacy Newsletter - December 2011, p. 5.
<html>Hosted by <a href="http://www.openwetware.org"><img src="http://openwetware.org/images/0/01/80x15_openwetware.png" border="0" /></a></html>
